Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Comments on Patel et al.'s "Randomized trial of infusion set function: steel versus teflon": early catheter failures may differ according to teflon catheter model.

Renard E, Boizel R.

Diabetes Technol Ther. 2014 Aug;16(8):545-6. doi: 10.1089/dia.2014.0058. Epub 2014 Jun 26. No abstract available.

PMID:
24967507
2.

Randomized trial of infusion set function: steel versus teflon.

Patel PJ, Benasi K, Ferrari G, Evans MG, Shanmugham S, Wilson DM, Buckingham BA.

Diabetes Technol Ther. 2014 Jan;16(1):15-9. doi: 10.1089/dia.2013.0119. Epub 2013 Oct 3.

3.

Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.

Højbjerre L, Skov-Jensen C, Kaastrup P, Pedersen PE, Stallknecht B.

Diabetes Technol Ther. 2009 May;11(5):301-6. doi: 10.1089/dia.2008.0061. Erratum in: Diabetes Technol Ther. 2010 Jul;12(7):586.

PMID:
19425878
4.
5.

Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients.

Kostev K, Rockel T, Rosenbauer J, Rathmann W.

Prim Care Diabetes. 2014 Dec;8(4):346-51. doi: 10.1016/j.pcd.2014.03.006. Epub 2014 Apr 13.

PMID:
24735947
7.

Response to comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122.

Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon A, Chadwick TJ, Barendse S, Stocken DD, Brennand C, Marshall SM, Wood R, Speight J, Kerr D, Flanagan D, Heller SR, Evans ML, Shaw JA.

Diabetes Care. 2014 Dec;37(12):e272-3. doi: 10.2337/dc14-1947. No abstract available.

PMID:
25414405
8.

The effect of tubing dwell time on insulin adsorption during intravenous insulin infusions.

Thompson CD, Vital-Carona J, Faustino EV.

Diabetes Technol Ther. 2012 Oct;14(10):912-6. Epub 2012 Jul 2.

9.

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.

Blumer I.

Diabetes Care. 2005 Mar;28(3):763; author reply 763-4. No abstract available.

PMID:
15735237
10.

Insulin pump therapy: a meta-analysis: response to Weissberg-Benchell et al.

DeVries JH, Heine RJ.

Diabetes Care. 2003 Aug;26(8):2485; author reply 2485-6. No abstract available.

PMID:
12882900
11.

Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.

Patte C, Pleus S, Wiegel C, Schiltges G, Jendrike N, Haug C, Freckmann G.

Diabetes Technol Ther. 2013 Apr;15(4):289-94. doi: 10.1089/dia.2012.0319. Epub 2013 Feb 21.

PMID:
23427865
12.

The journey to metabolic control in diabetes: many more miles to go.

Silverstein JH, Rosenbloom AL.

J Pediatr. 2003 Dec;143(6):704-6. No abstract available.

PMID:
14657811
14.

Neonatal diabetes and insulin pump therapy.

Beardsall K, Pesterfield CL, Acerini CL.

Arch Dis Child Fetal Neonatal Ed. 2011 May;96(3):F223-4. doi: 10.1136/adc.2010.196709. Epub 2010 Nov 29.

PMID:
21115555
15.

Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS).

New JP, Ajjan R, Pfeiffer AF, Freckmann G.

Diabet Med. 2015 May;32(5):609-17. doi: 10.1111/dme.12713. Epub 2015 Feb 20.

PMID:
25661981
16.

Insulin-pump therapy for type 1 diabetes mellitus.

Blumer I, Edelman SV, Hirsch IB.

N Engl J Med. 2012 Jul 26;367(4):383; author reply 383-4. doi: 10.1056/NEJMc1206221#SA1. No abstract available.

PMID:
22830479
17.

Access to insulin pump therapy and continuous glucose monitoring - is it an even playing field?

Hitman GA.

Diabet Med. 2012 Aug;29(8):971. doi: 10.1111/j.1464-5491.2012.03734.x. No abstract available.

PMID:
22803777
18.

A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion.

Liebl A, Hoogma R, Renard E, Geelhoed-Duijvestijn PH, Klein E, Diglas J, Kessler L, Melki V, Diem P, Brun JM, Schaepelynck-Bélicar P, Frei T; European DiaPort Study Group.

Diabetes Obes Metab. 2009 Nov;11(11):1001-8. doi: 10.1111/j.1463-1326.2009.01059.x. Epub 2009 Sep 9.

PMID:
19740082
19.

[Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus].

Casas-Oñate ML, Montoya-Martínez D.

Enferm Clin. 2010 Jul-Aug;20(4):216-21. doi: 10.1016/j.enfcli.2010.05.002. Epub 2010 Jun 18. Spanish.

PMID:
20561806
20.

Severe autonomic neuropathy treated with subcutaneous insulin infusion.

Prendergast JJ, Aubry W.

Diabetes Care. 1996 Jan;19(1):90. No abstract available.

PMID:
8720543

Supplemental Content

Support Center